ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Software Engineer IV at Beacon Biosignals - ApplyBlast

Software Engineer IV

Beacon Biosignals

6 days ago

2.6 on Glassdoor

Remote

Full Time

Senior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

Beacon Biosignals is seeking a Software Engineer IV to join the Datastore team, focusing on the design and scaling of backend systems for data infrastructure. This role involves leading the architecture of complex systems, managing PostgreSQL data models, Kafka-driven event pipelines, and a GraphQL API to support clinical and scientific data workflows. The position offers a 100% remote work option within the U.S. and involves collaboration across platform, application, and scientific teams to implement APIs and improve operational robustness.

Responsibilities

Lead design and architecture for complex data infrastructure systems
Develop and maintain PostgreSQL data models and Kafka-driven event pipelines
Mentor engineers and improve team practices, tooling, and documentation

Skills

About Beacon Biosignals

beacon.bio

Headquarters

Boston, Massachusetts, United States

Company Size

11-50 employees

Founded

2019

View Profile

Beacon Biosignals is an AI-driven neurotechnology company building the future of brain health through precision neuroscience. The company offers a leading precision medicine platform for collecting, integrating, and analyzing EEG and neurophysiological data across the full drug development lifecycle, supporting clinical trials for biopharma, as well as scalable at-home sleep testing diagnostics for sleep physicians, neurologists, and primary care providers. Beacon is also building the world's largest clinically validated neurophysiology dataset to enable deeper understanding of brain health and more targeted, personalized therapies.